EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer

Shinkichi Takamori iD, Tateaki Naito iD, Nobuko Konishi iD, Tetsuya Tsuji iD, Ikumi Takashima, Ryotaro Ide iD, Masakazu Fujiwara iD, Atsuki Yamamoto iD, Yusuke Takagi, Mizue Ogi iD, Shinya Uematsu, Hiroshi Kitagawa iD und 1 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70709 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Shinkichi Takamori und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Perioperative Care. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca K.K..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adjuvant chemotherapy can improve outcomes for patients who have undergone lung cancer resection, and perioperative rehabilitation may help maintain the physical condition necessary to receive adjuvant chemotherapy. This observational cohort study investigated the impact of perioperative rehabilitation on the administration of postoperative adjuvant chemotherapy, focusing on platinum‐based chemotherapies, using a proprietary database of health claims and administrative data from over 450 acute care hospitals in Japan. Patients with Stage II–IIIB non‐small cell lung cancer (NSCLC) who underwent surgery between 2017 and 2023 within 180 days of a record of lung cancer diagnosis were eligible. Primary outcome was the proportion of patients who initiated adjuvant platinum‐based chemotherapy within 90 days after surgery. Adjusted risk differences were estimated using inverse probability of treatment weighted modified least‐squares regression. A total of 8111 patients with Stage II–IIIB NSCLC were included in this study, of whom 5158 (median age: 73.0 years; 72.0% male) received perioperative rehabilitation and 2953 (72.0 years; 69.8% male) did not. Adjuvant chemotherapy (within 90 days of surgery; primary outcome) was initiated in 31.1% (1489/4794) of patients with rehabilitation versus 29.1% (788/2708) in patients without rehabilitation. The adjusted risk difference was 4.1% (adjusted risk difference estimate: 0.041 [95% confidence interval: 0.021, 0.062]; p < 0.001). This study demonstrated that perioperative rehabilitation was associated with more frequent initiation of adjuvant platinum‐based chemotherapy within 90 days after surgery in patients with Stage II–IIIB NSCLC. Additional research is warranted to confirm the clinical benefits of the broader implementation of perioperative rehabilitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPerioperative CareHumansMaleChemotherapy, AdjuvantFemaleAgedAged, 80 and overMiddle AgedJapanNeoplasm StagingPneumonectomy

Stichwörter der Autor:innen

adjuvant chemotherapynon‐small cell lung cancerperioperative rehabilitation

Autor:innen und Institutionen

  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Department of Rehabilitation, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Medical Department, AstraZeneca K.K., Osaka, Japan.

ORCID-Profile: Shinkichi Takamori, Tateaki Naito, Nobuko Konishi, Tetsuya Tsuji, Ryotaro Ide, Masakazu Fujiwara, Atsuki Yamamoto, Mizue Ogi, Hiroshi Kitagawa, Koichi Takayama

Förderung

  • AstraZeneca K.K.

Zitieren

APA

Takamori, S., Naito, T., Konishi, N., Tsuji, T., Takashima, I., Ide, R., Fujiwara, M., Yamamoto, A., Takagi, Y., Ogi, M., Uematsu, S., Kitagawa, H., & Takayama, K. (2026). Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.70709

Vancouver

Takamori S, Naito T, Konishi N, Tsuji T, Takashima I, Ide R, et al. Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer. International Journal of Cancer. 2026. doi:10.1002/ijc.70709

BibTeX
@article{Takamori2026,
  author = {Takamori, Shinkichi and Naito, Tateaki and Konishi, Nobuko and Tsuji, Tetsuya and Takashima, Ikumi and Ide, Ryotaro and Fujiwara, Masakazu and Yamamoto, Atsuki and Takagi, Yusuke and Ogi, Mizue and Uematsu, Shinya and Kitagawa, Hiroshi and Takayama, Koichi},
  title = {Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70709}
}
Kostenlos starten →